CVE-2022-47376

highpriority · track · 29EPSS 0.002 · 5 %ileEUUS
grimoire priorityP2 · Scheduled
Exploitable?
—
no known exploitation
Likely / severe?
0.16% (5th) EPSS
CVSS 7.3 · high
Is it mine?
4 products
Check your exposure
Who says so?
4 sources
cnnvd · enisa_euvd · cisa_csaf_ot · nvd

EPSS · scored 2026-10-27

The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.

01

remediations

Vendor fix, mitigation, or workaround guidance, as published by each source.

A vendor fix is available.

  • FixedAlaris Infusion Central softwarecisa_csaf_ot

    BD is directly reaching out to the small group of customers who may be impacted by this vulnerability to initiate remediation.

  • MitigationAlaris Infusion Central softwarecisa_csaf_ot

    Change passwords periodically per best security practice.

02

cvss

Technical severity, 0–10. One row per scoring source.

7.3
010

base score 0–10 · higher = more severe · hover a vector to decode⚠ sources disagree · medium–high · 6.7–7.3

v3.17.3highCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:Lprimary · NVD / NIST USexploitability 1.8 · impact 5.5
v3.17.3highCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:Lsecondary · CISA US
v3.17.3highCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:Lsecondary · ENISA EU
v3.17.3highCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:Lsecondaryexploitability 1.8 · impact 5.5
v3.16.7mediumCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L/E:Usecondary · CVSS-BT (t0sche)
03

ssvc

A stakeholder decision — act, attend, or track — from exploitation and impact.

Exploitation: none · Automatable: no · Technical Impact: totalcoordinatorcisa_ssvcUS
04

weaknesses

The CWE weakness classes this flaw belongs to.

CWE-522USprimaryCWE-257USCWE-257US
05

affected products (4)

Products and version ranges known to be affected.

06

advisories (1)

Vendor and ecosystem advisories describing this.

  • ICSMA-23-047-01BD Alaris Infusion Central2023-02-16icsa · cisa_csaf_otUS

    This updated advisory is a follow-up to the original advisory titled ICSMA-23-047-01 BD Alaris Infusion Central that was published February 16, 2023, to the ICS webpage on www.cisa.gov/uscert.

07

also known as (3)

Other names and identifiers for this entity.

08

sources

Which sources assert this record, and when.

cnnvdenisa_euvdcisa_csaf_otnvdNVDCVE.orgMITRE
published 2023-06-13modified 2026-06-17
10

references (4)

External citations — patches, advisories, analysis.

scry

Attackers weaponise vulnerabilities like this against internet-exposed services. See what is exposed on your perimeter with a free passive scan.

Free scan